Properties of mutant SHV-5 β-lactamases constructed by substitution of isoleucine or valine for methionine at position 69

被引:10
作者
Giakkoupi, P
Miriagou, V
Gazouli, M
Tzelepi, E
Legakis, NJ
Tzouvelekis, LS
机构
[1] Hellen Pasteur Inst, Dept Bacteriol, Athens 11521, Greece
[2] Hellen Pasteur Inst, Qual Control Lab, Athens 11521, Greece
[3] Univ Athens, Sch Med, Dept Microbiol, GR-11527 Athens, Greece
关键词
D O I
10.1128/AAC.42.5.1281
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The effect of replacement of Met-69 by Ile or Val on the properties of the extended-spectrum beta-lactamase SHV-5 was studied. Mutant enzymes were constructed by site-specific mutagenesis and expressed under isogenic conditions in Escherichia coli DH5 alpha cells. Compared with SHV-5, the mutant beta-lactamases conferred lower levels of beta-lactam resistance and were less efficient in hydrolyzing ampicillin, cephalothin, and cefotaxime, The substitutions rendered SHV-5 less susceptible to inhibition by clavulanate, sulbactam, and tazobactam; however, the MICs of penicillin-inhibitor combinations remained similar, suggesting an attenuation of penicillinase activity.
引用
收藏
页码:1281 / 1283
页数:3
相关论文
共 23 条
[1]   A STANDARD NUMBERING SCHEME FOR THE CLASS-A BETA-LACTAMASES [J].
AMBLER, RP ;
COULSON, AFW ;
FRERE, JM ;
GHUYSEN, JM ;
JORIS, B ;
FORSMAN, M ;
LEVESQUE, RC ;
TIRABY, G ;
WALEY, SG .
BIOCHEMICAL JOURNAL, 1991, 276 :269-270
[2]   CHARACTERIZATION OF A BETA-LACTAMASE FROM CLOSTRIDIUM CLOSTRIDIOFORME [J].
APPELBAUM, PC ;
SPANGLER, SK ;
PANKUCH, GA ;
PHILIPPON, A ;
JACOBS, MR ;
SHIMAN, R ;
GOLDSTEIN, EJC ;
CITRON, DM .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1994, 33 (01) :33-40
[3]   NUCLEOTIDE-SEQUENCE OF THE SHV-5 BETA-LACTAMASE GENE OF A KLEBSIELLA-PNEUMONIAE PLASMID [J].
BILLOTKLEIN, D ;
GUTMANN, L ;
COLLATZ, E .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (12) :2439-2441
[4]   CHARACTERIZATION OF A NEW TEM-TYPE BETA-LACTAMASE RESISTANT TO CLAVULANATE, SULBACTAM, AND TAZOBACTAM IN A CLINICAL ISOLATE OF ESCHERICHIA-COLI [J].
BLAZQUEZ, J ;
BAQUERO, MR ;
CANTON, R ;
ALOS, I ;
BAQUERO, F .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (10) :2059-2063
[5]   Construction and characterization of an OHIO-1 beta-lactamase bearing Met69Ile and Gly238Ser mutations [J].
Bonomo, RA ;
Knox, JR ;
Rudin, SD ;
Shlaes, DM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (09) :1940-1943
[6]   OHIO-1 BETA-LACTAMASE RESISTANT TO MECHANISM-BASED INACTIVATORS [J].
BONOMO, RA ;
CURRIEMCCUMBER, C ;
SHLAES, DM .
FEMS MICROBIOLOGY LETTERS, 1992, 92 (01) :79-82
[7]   Tazobactam is a potent inactivator of selected inhibitor-resistant class A beta-lactamases [J].
Bonomo, RA ;
Rudin, SA ;
Shlaes, DM .
FEMS MICROBIOLOGY LETTERS, 1997, 148 (01) :59-62
[8]   NEW PLASMID BORNE BETA-LACTAMASES - BIOCHEMICAL CHARACTERISTICS OF EXTENDED BROAD-SPECTRUM BETA-LACTAMASES [J].
BUSH, K ;
SINGER, SB .
INFECTION, 1989, 17 (06) :429-433
[9]  
BUSH K, 1995, AGENTS CHEMOTHER, V49, P1211
[10]  
DELAIRE M, 1992, J BIOL CHEM, V267, P20600